Lincoln Pharmaceuticals Limited (LINCOLN.NS) NSE

556.25

-2.45(-0.44%)

Updated at September 08 03:29PM

Currency In INR

Valuation

Market Cap11.06B
Enterprise Value10.84B
P/E Ratio12.87
PEG Ratio2.65
Price/Sales Ratio1.76
Price/Book Ratio1.66
Enterprise/Revenue1.74
Enterprise/EBITDA8.46

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.14
Operating Margin0.14

Management Effectiveness

Return On Assets0.11
Return On Equity0.14

Income Statement

Revenue6.23B
Revenue/Share314.61
Gross Profit3.32B
EBITDA1.24B
Net Income823.46M
Diluted EPS41.11

Balance Sheet

Total Cash1.97B
Total Cash/Share93.45
Total Debt0
Total Debt/Equity0
Current Ratio4.71
Book Value Per Share335.41

Price History

52-Week Change-28.05
52-Week High979.5
52-Week Low499
Moving Average 50 Days551.93
Moving Average 200 Days624.72

Statistics

Average Volume128,280
Shares Outstanding20.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.8
Trailing Annual Dividend Yield0.32
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A